Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

PREPARATION AND USE OF ANDROGENIC COMPOUNDS

  • Read more about PREPARATION AND USE OF ANDROGENIC COMPOUNDS
European Patent
01922911.1
Filed on 2001-03-30

Method for preparing 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione, intermediates thereof, and methods for preparation of such intermediates

  • Read more about Method for preparing 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione, intermediates thereof, and methods for preparation of such intermediates
Japan
508726/2006
Filed on 2005-08-25

Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates

  • Read more about Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates
European Patent
04711161.2
Filed on 2004-02-12

Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates.

  • Read more about Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates.
Canada
2516319
Filed on 2004-02-13

Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates

  • Read more about Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
Australia
2004217988
Filed on 2004-02-13

An Alternate Route To 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione (CDB-2914)

  • Read more about An Alternate Route To 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione (CDB-2914)
US Application 10/542,580
Filed on 2005-07-19

NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF

  • Read more about NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF
Patent Cooperation Treaty
PCT/US98/19782
Filed on 1998-09-23

Additional Methods For Preparing Conjugates Of Poly-gamma-D-glumate Acid (PGA) From Bacillus Anthracis Or Synthetic PGA Peptides Bound To Proteins

  • Read more about Additional Methods For Preparing Conjugates Of Poly-gamma-D-glumate Acid (PGA) From Bacillus Anthracis Or Synthetic PGA Peptides Bound To Proteins
Patent Cooperation Treaty
PCT/US2005/19678
Filed on 2005-06-03

Tri-Functional Nanoparticles

  • Read more about Tri-Functional Nanoparticles
US Application 11/135,380
Filed on 2005-05-24

Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione

  • Read more about Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione
Luxembourg
00989551.7
Filed on 2000-12-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • Page 104
  • Page 105
  • Page 106
  • Page 107
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health